Landscape Capital Management L.L.C. cut its stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 59.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,111 shares of the company’s stock after selling 29,703 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in BlackRock Health Sciences Trust were worth $763,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also bought and sold shares of the stock. HBK Sorce Advisory LLC boosted its stake in shares of BlackRock Health Sciences Trust by 14.8% during the fourth quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock valued at $311,000 after purchasing an additional 1,057 shares during the period. Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust during the 4th quarter valued at $832,000. AlphaStar Capital Management LLC purchased a new stake in BlackRock Health Sciences Trust during the 4th quarter valued at $878,000. Janney Montgomery Scott LLC grew its holdings in BlackRock Health Sciences Trust by 40.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after acquiring an additional 9,455 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of BlackRock Health Sciences Trust in the fourth quarter valued at about $3,250,000.
BlackRock Health Sciences Trust Stock Down 4.8 %
Shares of NYSE:BME opened at $36.32 on Monday. BlackRock Health Sciences Trust has a 12 month low of $35.92 and a 12 month high of $42.64. The company has a 50-day moving average price of $39.68 and a 200-day moving average price of $39.83.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- How Investors Can Find the Best Cheap Dividend Stocks
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- What is the FTSE 100 index?
- Disney 2025 Shareholders: Major Updates for Investors
- Health Care Stocks Explained: Why You Might Want to Invest
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.